| Philip Bao, MD | |
|
11050 Parkview Circle Dr, Fort Wayne, IN 46845-1739 | |
| (833) 274-8326 | |
| (260) 266-7935 |
| Full Name | Philip Bao |
|---|---|
| Gender | Male |
| Speciality | Surgical Oncology |
| Experience | 24 Years |
| Location | 11050 Parkview Circle Dr, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881735207 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkview Regional Medical Center | Fort wayne, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Parkview Health System Inc | 2163336967 | 1167 |
News Archive
VIVUS, Inc. today announced positive results from REVIVE (TA-301), a phase 3 pivotal study evaluating the safety and efficacy of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED), in 646 patients.
Before bite-sized crustaceans like crayfish, shrimp and prawns land on our dinner plates, they first have to get fat themselves - and it turns out they relish the freshwater snails that transmit the parasite that causes schistosomiasis, the second most devastating parasitic disease worldwide, after malaria.
Northwestern Medicine scientists have discovered a new cause of Parkinson's disease - mutations in a gene called TMEM230. This appears to be the third gene definitively linked to confirmed cases of the common movement disorder.
Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.
The Michael J. Fox Foundation for Parkinson's Research (MJFF) will provide $2.5 million to support Ceregene Inc.'s new Phase 2 study of CERE-120. This novel gene therapy product delivers the gene for neurturin, a potent neurotrophic (growth) factor that has shown potential to improve the status of degenerating neurons in both preclinical and clinical studies. CERE-120 has the potential to improve motor function as well as slow Parkinson's disease (PD) progression.
› Verified 2 days ago
| Entity Name | Parkview Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932130952 PECOS PAC ID: 2163336967 Enrollment ID: O20031117000288 |
News Archive
VIVUS, Inc. today announced positive results from REVIVE (TA-301), a phase 3 pivotal study evaluating the safety and efficacy of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED), in 646 patients.
Before bite-sized crustaceans like crayfish, shrimp and prawns land on our dinner plates, they first have to get fat themselves - and it turns out they relish the freshwater snails that transmit the parasite that causes schistosomiasis, the second most devastating parasitic disease worldwide, after malaria.
Northwestern Medicine scientists have discovered a new cause of Parkinson's disease - mutations in a gene called TMEM230. This appears to be the third gene definitively linked to confirmed cases of the common movement disorder.
Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.
The Michael J. Fox Foundation for Parkinson's Research (MJFF) will provide $2.5 million to support Ceregene Inc.'s new Phase 2 study of CERE-120. This novel gene therapy product delivers the gene for neurturin, a potent neurotrophic (growth) factor that has shown potential to improve the status of degenerating neurons in both preclinical and clinical studies. CERE-120 has the potential to improve motor function as well as slow Parkinson's disease (PD) progression.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Philip Bao, MD 11109 Parkview Plaza Dr # 117, Fort Wayne, IN 46845-1701 Ph: () - | Philip Bao, MD 11050 Parkview Circle Dr, Fort Wayne, IN 46845-1739 Ph: (833) 274-8326 |
News Archive
VIVUS, Inc. today announced positive results from REVIVE (TA-301), a phase 3 pivotal study evaluating the safety and efficacy of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED), in 646 patients.
Before bite-sized crustaceans like crayfish, shrimp and prawns land on our dinner plates, they first have to get fat themselves - and it turns out they relish the freshwater snails that transmit the parasite that causes schistosomiasis, the second most devastating parasitic disease worldwide, after malaria.
Northwestern Medicine scientists have discovered a new cause of Parkinson's disease - mutations in a gene called TMEM230. This appears to be the third gene definitively linked to confirmed cases of the common movement disorder.
Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.
The Michael J. Fox Foundation for Parkinson's Research (MJFF) will provide $2.5 million to support Ceregene Inc.'s new Phase 2 study of CERE-120. This novel gene therapy product delivers the gene for neurturin, a potent neurotrophic (growth) factor that has shown potential to improve the status of degenerating neurons in both preclinical and clinical studies. CERE-120 has the potential to improve motor function as well as slow Parkinson's disease (PD) progression.
› Verified 2 days ago
Dr. Ian H. Cook, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2121 Lake Ave, Veterans Affairs Medical Center, Fort Wayne, IN 46805 Phone: 260-426-5431 | |
Brett J. Guinn, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2510 E Dupont Rd Ste 210, Fort Wayne, IN 46825 Phone: 260-458-3710 Fax: 260-458-3714 | |
Dr. Paul Mitchell Bauer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Lutheran Hospital, 7950 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-435-7001 | |
Lindsay B Hardley, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 11050 Parkview Circle Dr, Fort Wayne, IN 46845 Phone: 833-724-8326 Fax: 260-425-6845 | |
Dr. Keith David Clancy, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 7900 W Jefferson Blvd Ste 306, Fort Wayne, IN 46804 Phone: 260-458-3610 Fax: 260-458-3611 | |
Dr. Charles Michael Morgan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 7950 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-432-2297 Fax: 260-434-6481 | |
Jeffery A Yoder, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 305, Fort Wayne, IN 46845 Phone: 260-484-9611 Fax: 260-484-1004 |